Menu
Washingtoner
  • Home
  • Health
  • Books
  • Business
  • Artificial Intelligence
  • Billionaires
  • Construction
  • Financial
  • Society
Washingtoner

Gary S. Monroe, C.D. Accelerates Promising New Treatments For Cocaine And Methamphetamine Addicts
Washingtoner/10106757

Trending...
  • Arizona Christian Homeschools Launches Statewide Directory
  • Ricci's Painting & Contracting Expands Home Transformation Services
  • San Diego's newest marketing firm is boring on purpose — it's working
Accelerated Treatment Systems
SHERMAN OAKS, Calif. - Washingtoner -- Gary S. Monroe, C.D. (Clinical Director) for Accelerated Treatment Systems, in Sherman Oaks, California, recently met with Mike Pavlovich, PharmD, FAPhA, of Westcliff Compounding Pharmacy, in Newport Beach, California, to discuss several promising treatments for Cocaine and Methamphetamine addicts.

The discussion centered around several medications (GABAergic medications, such as baclofen, tiagabine, and topiramate, and the glutamatergic medication, modafinil.  Disulfiram, an old treatment for alcohol dependence, may also have efficacy for cocaine relapse prevention.) that block cocaine euphoria, or reduce cocaine craving and have shown potential to reduce the chances of relapse. Two studies regarding Methamphetamine addiction have shown promising results with the use of Naltrexone, Bupropion, and A118G Polymorphism.

Accelerated Treatment Systems plans on conducting several studies of their own with these treatments.  "We plan to get moving quickly, to bring hope to individuals who suffer from this debilitating issue and bring in the appropriate investment and scientific research," said Mr. Gary S. Monroe.

More on Washingtoner
  • Kasinohai Audit: Most Slots Could Be Affected by Finland's Draft Gambling Rules
  • Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
  • City of Tacoma Observes Independence Day
  • Make America French Again Launches National Campaign
  • AI Researcher Releases Punk Album "You Can't Kill The Signal" In Response To Mythos and Fable Ban

About Gary S. Monroe
Gary S. Monroe is an Entrepreneur, an Entertainment Industry veteran, and the Founder of Accelerated Treatment Systems in Sherman Oaks, California, where he serves as Clinical Director.  He has been in recovery for 29 years.

https://www.linkedin.com/in/gary-monroe-lion-62449287

About Mike Pavlovich
Mike Pavlovich, PharmD, FAPhA is a Pharmacist and the President of Westcliff Compounding Pharmacy, a multi-disciplinary pharmaco-medical practice specializing in pain management and pharmaceutical compounding based in Newport Beach, California. Mr. Pavlovich served as a Trustee for the American Pharmacists Association from 2008-2014 and is a graduate of the University of the Pacific.

https://www.westcliffcompounding.com/index.html

About Accelerated Treatment Systems
Accelerated Treatment Systems is a Sherman Oaks, California, based Addiction treatment facility founded by Gary S. Monroe, C.D.

https://acceleratedtreatmentsystems.com/

Contact
Justin Waters
***@tonupinc.com


Source: Accelerated Treatment Systems

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • A Novelist and an Essayist Walk Into a Podcast and Reach the Same Conclusion
  • 100+ Episodes In, Liftoff with Keith Newman Tells Founders to Stop Publishing More
  • Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
  • Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
  • Webinar Announcement: Built for Trust: Latitude's 0 to 1 Compliance Playbook for Modern Cross-Border Payments
  • OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
  • Dentists launch independent platform to help practices choose the right technology
  • Contracting Resources Group Recognized by The Daily Record as a 2026 In the Lead: Best Women-Owned Businesses Honoree
  • Woodforest Acceptance Solutions and AlpacaBOSS Launch Partnership
  • Spokane: SPD is Investigating a Shooting that Occurred Early Monday
  • Tacoma Residents Report Improved Satisfaction in 68 of 80 City Service Areas in 2026 Community Survey
  • New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026
  • 80 Arts, Culture, Heritage, and Science Organizations Funded by Tacoma Creates for 2026-2027
  • Deputy Mayor Joe Bushnell Presents Tacoma Minimum Wage Community and Stakeholder Engagement Report to Economic Development Committee
  • Spokane: America's 250th Celebrated in Riverfront Park with Incredible Lineup
  • Spokane: City Details Fourth of July Activities, Closures
  • Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
  • Tacoma: System Development Charges for Wastewater and Stormwater Utilities to Take Effect on July 1
  • Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
  • IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
_catLbl0 _catLbl1

Popular on Washingtoner

  • Kevin Francis Design Introduces CHROMA, a Collection of Saturated Solid Color Wool Rugs - 324
  • Tacoma Dome Welcomes Class of 2026
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • A Foundational Claim in Human Secrecy Goes Public
  • Spokane: Chat & Chew District 3 Council Members
  • From Broken to Soaring Week 40
  • Spokane City Council Passes Aggressive Speeding Ordinance
  • Spokane: Notice from SPD as Team Egypt Arrives & FIFA Events Begin
  • City of Tacoma to Implement Temporary Road Closures and Traffic Restrictions on June 12
  • SPD Investigate Homicide In North Spokane - One Male In Custody

Similar on Washingtoner

  • Dentists launch independent platform to help practices choose the right technology
  • IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
  • Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
  • Sexually Abused in a Psychiatric Hospital or Psychiatrist's or Psychologist's Office? CCHR Urges Survivors to Reach Out to It
  • Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
  • $20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
  • HomeCentris Home Health Achieves 5-Star CMS Rating
  • HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
  • Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute